HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Role of metallothioneins 1 and 2 in ocular neovascularization.

AbstractPURPOSE:
The incidence of blindness is increasing, in part, because of abnormal ocular neovascularization. Anti-VEGF therapies have yielded impressive results; however, they are not a cure for blindness. Recently, metallothioneins (MTs) 1 and 2 have been implicated in the process of angiogenesis. Therefore, we investigated whether MT-1 and MT-2 were also involved in ocular neovascularization.
METHODS:
The concentrations of MT-1 and MT-2 (hereafter MT-1/2) were observed by ELISA. We examined the role of MT-1/2 in ocular neovascularization by using both an oxygen-induced retinopathy (OIR) model and a laser-induced choroidal neovascularization (CNV) model. We investigated the localization of MT-1/2 in retina. Furthermore, we investigated the expression of hypoxia-inducible factor (HIF)-1α and VEGF in OIR. In vitro, we investigated the degradation of HIF-1α.
RESULTS:
The MT-1/2 were significantly elevated in proliferative diabetic retinopathy patients. Ocular neovascularization, which was induced in both the OIR model and the CNV model, was decreased in MT-1/2 knockout (KO) mice. We confirmed that although MT-1/2 was expressed throughout the murine retina, its expression levels were highest in the endothelial cells. Further, OIR enhanced MT-1/2 expression in the retina. Interestingly, in the OIR model, both HIF-1α and VEGF levels were significantly decreased in the retina of MT-1/2 KO mice. In addition, we found that knockdown of MT-1/2 accelerated ubiquitination of HIF-1α.
CONCLUSIONS:
These results indicate that MT-1/2 are involved in retinal and choroidal neovascularization, and that MT-1/2 might be a new therapeutic target in diseases in which ocular angiogenesis is implicated.
AuthorsShinsuke Nakamura, Masamitsu Shimazawa, Yuki Inoue, Shinsuke Takata, Yasushi Ito, Kazuhiro Tsuruma, Tsunehiko Ikeda, Akiko Honda, Masahiko Satoh, Hideaki Hara
JournalInvestigative ophthalmology & visual science (Invest Ophthalmol Vis Sci) Vol. 55 Issue 10 Pg. 6851-6860 (Sep 23 2014) ISSN: 1552-5783 [Electronic] United States
PMID25249600 (Publication Type: Journal Article)
CopyrightCopyright 2014 The Association for Research in Vision and Ophthalmology, Inc.
Chemical References
  • Matrix Metalloproteinase 2
  • Matrix Metalloproteinase 1
Topics
  • Aged
  • Animals
  • Blotting, Western
  • Disease Models, Animal
  • Enzyme-Linked Immunosorbent Assay
  • Eye Diseases (enzymology, pathology)
  • Female
  • Fluorescein Angiography
  • Fundus Oculi
  • Humans
  • Immunoblotting
  • Immunohistochemistry
  • Male
  • Matrix Metalloproteinase 1 (metabolism)
  • Matrix Metalloproteinase 2 (metabolism)
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Middle Aged
  • Neovascularization, Pathologic (enzymology, pathology)
  • Vitreous Body (enzymology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: